Conferences &
Events

The largest healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

The combined annual meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and CIBMTR (Center for International Blood and Marrow Transplant Research) will cover the latest scientific updates, new technologies, and innovative products in HCT, cellular therapy, and gene therapy.

IO360˚ convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.

Hosted by the Myeloma Institute at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, in collaboration with the Multiple Myeloma Research Foundation (MMRF), International Myeloma Foundation (IMF), and HealthTree Foundation for Multiple Myeloma, this workshop will bring together leading experts in multiple myeloma who will discuss the use of measurable residual disease (MRD) in clinical and trial settings.

ASCO is a meeting of the global oncology community focused on the latest innovations in cancer science and education.

The EHA2025 Congress will highlight the latest news in hematology and its subspecialties, including cutting-edge evidence-based approaches to diagnosis and treatment, highly anticipated research data and the latest innovations.

ASH is the world’s largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.

SITC’s Annual Meeting is the largest cancer immunotherapy conference.

This event will cover the future of the biotech industry, including the biotech IPO outlook, developments in cell therapy and more.

The CAR TCR Summit brings together the global cell therapy community to explore discovery through to commercialization to deliver safe, effective and commercially viable CAR and TCR therapies.

Annual Meeting of the Society of Hematologic Oncology focuses specifically on new advances and practical clinical applications in the field of hematologic malignancies. The speakers are a multidisciplinary group of internationally recognized experts that represent the spectrum of these diseases.

At the FOCIS Annual Meeting, researchers and clinicians will share knowledge across immune-mediated diseases.

The EHA2024 Hybrid Congress scientific program will focus on cutting-edge hematology and various topics, including hemostasis and thrombosis, hematologic malignancies, transfusion medicine, and stem cell transplantation.

ASCO is a meeting of the global oncology community focused on the latest innovations in cancer science and education.

IO360˚ convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.

PMWC gathers recognized leaders, top global researchers and medical professionals, plus innovators across healthcare and biotechnology sectors and showcases the latest practical content that helps close the knowledge gap among different sectors.

The largest healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

The FOCIS Annual Meeting is an incubator for developing scientists and clinicians to coalesce with relevant biotech and pharmaceutical industries to improve the field of translational research throughout medicine.

The EHA2023 Hybrid Congress educational and scientific program will highlight state-of-the-art clinical practice, the latest findings in hematology research, and recent approaches on the diagnosis and treatment of hematologic diseases.

Global thought-leaders and industry experts discuss the burning issues, latest innovations, and future trends impacting biotech.

ASCO is a meeting of the global oncology community focused on the latest innovations in cancer science and education.

The 5th Treg Summit is a forum to accelerate progression of IL-2, mutein, CAR-Tregs and more, to redefine treatments for autoimmunity, transplant and inflammation.

The American Association of Immunologists (AAI) annual meeting features innovative developments from scientists at every career stage, including major lectures from some of the world’s most prominent immunologists, and podium and poster presentations of abstracts.

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine.

PMWC gathers recognized leaders, top global researchers and medical professionals, plus innovators across healthcare and biotechnology sectors and showcases the latest practical content that helps close the knowledge gap among different sectors.

With more than 18,000 members from nearly 100 countries, ASH is the world’s largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.

Annual meeting provides a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.

The CAR-TCR Summit focuses on discovery through commercialization of safe, effective and commercially viable CAR and TCR therapies. Tracks include Discovery, Translation, Clinical Management, Early Phase Development, Manufacturing, CMC/Analytics, Logistics, and Market Access.

The Disease Prevention & Control Summit is a chance to partner, learn, connect, and make great strides towards preventing and combating infectious disease outbreaks of today and tomorrow.

PMWC gathers recognized leaders, top global researchers and medical professionals, plus innovators across healthcare and biotechnology sectors and showcases the latest practical content that helps close the knowledge gap among different sectors.

LSX aims to provide the world’s most influential and powerful global platform that will nurture and develop cross-industry partnerships, connect innovation to capital and forge and deepen relationships that will underpin the success of the global life science and healthcare industries.

The FOCIS Annual Meeting brings together researchers and clinicians in translational immunology to share knowledge across traditional disease borders and identify commonalities between treatments and therapies that are life-changing for those affected with immune-mediated diseases.

Despite mounting evidence that we need to look at the entire immune response, many academics, government researchers and vaccine makers are failing to include T-cell metrics in their studies. As a result, key questions remain unanswered: How long do vaccines last? Does everyone need a booster?

ASCO offers presentations on the latest research in cancer care. This year’s program will feature sessions complementing the meeting’s theme: Advancing Equitable Cancer Care Through Innovation.

Convening the world’s leading clinicians, industry executives, investors, patient advocates, payers, policy experts, and researchers, the 16th Annual Personalized Medicine Conference will facilitate a cross-sector exchange of perspectives on the scientific, business, and policy issues influencing the status and outlook for personalized medicine in the wake of a devastating pandemic that has upended the health care landscape.

Molecular diagnostics, more sophisticated approaches to analyzing health care data, and molecularly guided treatments for non-oncologic indications are expanding the frontiers of personalized medicine outside of oncology. But progress remains uneven across disease states. During this panel discussion, leaders in the field will join us to explore the opportunities and challenges for personalized medicine in multiple disease states.

Life Science Innovation Northwest is the Pacific Northwest’s largest annual life science conference bringing together investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community for a two-day event to discuss and feature some of the most compelling technology breakthroughs of our time.

The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain.

• What have we learnt from monitoring the immune responses to SARS-CoV-2 vaccines in different populations?
• How can this help inform future vaccine development?
• Why did the majority of mRNA vaccines work so well? What research has been done to understand the efficacy of these vaccines?

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

IO360˚ convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.

The premier event in malignant and non-malignant hematology. Join us at the Georgia World Congress Center in Atlanta, Georgia – or virtually – from December 11-14, 2021, to discover the newest advances in hematology.

The World Vaccine & Immunotherapy Congress is part of an award-winning series of conferences and exhibitions that are continuously growing becoming the largest and most established vaccine meetings of its kind across the globe.

The Society for Immunotherapy of Cancer’s (SITC) 36^th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C.

In this webcast, Dr. Thomas Snyder and Dr. Jabran Zahid will discuss how immunosequencing and identification of public T-cell receptor responses can be used to characterize HLA type and make connections of HLA to disease biology, immune response, and immune-driven therapies.

Two day virtual event bringing together those currently working hard to ease the globe out of the COVID-19 pandemic, and to prevent it from happening again.

Precision Medicine in the Era of a Pandemic Recovery

This briefing will be hosted by Adaptive Biotechnologies and the Personalized Medicine Coalition in cooperation with Rep. Tom Emmer (R-MN), Rep. Eric Swalwell (D-CA), Sen. Tim Scott (R-SC), and Sen. Kyrsten Sinema (D-AZ).

Cynthia Bens of the Personalized Medicine Coalition will moderate a discussion with leading experts.

This three-day conference will convene experts in immuno-oncology to discuss the latest research in the field. Topics under consideration will include how insights from the immune response to infection can inform our understanding of cancer immunotherapy, the COVID-19/Immuno-oncology interface, advances in multiple myeloma, cytokines, novel checkpoints and more.

Biology and technology are converging to change medicine. Join us for the 2021 STAT Health Tech Summit, which will bring you inside this transformation, with probing interviews, lively panels, and exciting demos.